Epirus to buy CHO tech and biosimilar developer Bioceros 09-Sep-2015 By Dan Stanton Epirus Biopharmaceuticals will bolster its biosimilar pipeline and gain a CHO platform through a $14m acquisition of Bioceros Holding.
Gallus doubles biologics capacity with acquisition of CMO Laureate 02-Oct-2013 By Dan Stanton Gallus Biopharmaceuticals has doubled its biologics process development services with the acquisition of contract manufacturer Laureate.